Free Access
Med Sci (Paris)
Volume 23, Number 5, Mai 2007
Page(s) 502 - 508
Section M/S revues
Published online 15 May 2007
  1. Karre K, Ljunggren HG, Piontek G, et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319 : 675–8. [Google Scholar]
  2. Ahmad A, Alvarez F. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J Leuk Biol 2004; 76 : 743–59. [Google Scholar]
  3. Lanier LL. NK Cell Recognition. Annu Rev Immunol 2005; 23 : 225–74. [Google Scholar]
  4. Katz G, Gazit R, Arnon T, et al. MHC class I independent recognition of NK activating receptor KIR2DS4. J Immunol 2004; 173 : 1819–25. [Google Scholar]
  5. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94 : 333–9. [Google Scholar]
  6. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295 : 2097–100. [Google Scholar]
  7. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102 : 814–9. [Google Scholar]
  8. Ruggeri L, Mancusi A, Capanni M, et al. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr Opin Immunol 2005; 17 : 211–7. [Google Scholar]
  9. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med 1971; 135 : 1513–28. [Google Scholar]
  10. Ogasawara K, Benjamin J, Takai R, et al. A role for NKG2D in NK cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 2005; 6 : 938–45. [Google Scholar]
  11. Lundqvist A, McCoy JP, Samsel L, et al. Reduction of GvHD and enhanced anti-tumor effects after adoptive infusion of alloreactive Ly49-mismatched NK-cells from MHC-matched donors. Blood 2007; 109 : 3603–6. [Google Scholar]
  12. Coupel S, Moreau N, Hamidou M, et al. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2006; online 19 décembre. [Google Scholar]
  13. Chan GW, Gorgun G, Miller KB, Foss FM. Persistence of host dendritic cells after transplantation is associated with graft versus host disease. Biol Blood Marrow Transpl 2003; 9 : 170–6. [Google Scholar]
  14. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 2004; 173 : 3653–9. [Google Scholar]
  15. Caligiuri MA, Velardi A, Scheinberg DA, et al. Immunotherapeutic approaches for hematologic malignancies. Hematology 2004; 337–53. [Google Scholar]
  16. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105 : 4878–84. [Google Scholar]
  17. Schaffer M, Malmberg KT, Ringden O, et al. Increased infection-related mortality in KIR ligand mismatched unrelated allogeneic transplantation in AML. Transplantation 2004; 78 : 1081–5. [Google Scholar]
  18. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002; 100 : 3825–7. [Google Scholar]
  19. Giebel S, Nowak I, Wojnar J, et al. Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. Transplant Proc 2006; 38 : 287–91. [Google Scholar]
  20. Verheyden S, Scots S, Duguet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemia relapses after related identical hematopoietic stem cell transplantation. Leukemia 2005; 19 : 1446–51. [Google Scholar]
  21. Kroger N, Binder T, Zabelina T, et al. Low number of donor activating killer immunoglobulin-like receptor (KIR) genes but not KIR-ligand mismatch prevents relapses and improves disease-free survival in leukemia patients after in vivo T cell-depleted unrelated stem cell transplantation. Transplantation 2006; 82 : 1024–30. [Google Scholar]
  22. Albertsson PA, Basse PH, Hokland M, et al. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol 2003; 24 : 603–9. [Google Scholar]
  23. Ishigami S, Natsugoe S, Tokuda K, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 2000; 88 : 577–83. [Google Scholar]
  24. Lee SG, Heo DS, Yoon S, et al. Effect of GM-CSF and IL-2 co-expression on anti-tumor immune response. Anticancer Res 2000; 20 : 2681–6. [Google Scholar]
  25. Son YI, Dallal RM, Mailliard RB, et al. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Res 2001; 61 : 884–8. [Google Scholar]
  26. Salih HR, Antropius A, Gieseke F, et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003; 102 : 1389–96. [Google Scholar]
  27. Fauriat C, Just-Landi S, Mallet F. Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemic cells in NCR dull phenotype induction. Blood 2007; 109 : 323–30. [Google Scholar]
  28. Demanet C, Moulder A, Denevers A. Downregulation of HLA-A and HLA-Bw6, but not HLA-Bw4 allospecificities, in leukemia cells: an escape mechanism from CTL and NK attack ? Blood 2004; 15 : 3122–30. [Google Scholar]
  29. Bukur J, Rebmann V, Gross-Wilde H, et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003; 63 : 4107–11. [Google Scholar]
  30. Tripathy P, Agarwal S. Non classical HLA-G antigen and its role in the cancer progression. Cancer Invest 2006; 24 : 178–86. [Google Scholar]
  31. Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 2005; 106 : 376–83. [Google Scholar]
  32. Koh CY, Blazar BR, George T, et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 2001; 97 : 3132–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.